Related references
Note: Only part of the references are listed.Vocalization Deficits in Mice Over-Expressing Alpha-Synuclein, a Model of Pre-Manifest Parkinson's Disease
Laura M. Grant et al.
BEHAVIORAL NEUROSCIENCE (2014)
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease
M. Angela Cenci
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice
Luz M. Suarez et al.
BIOLOGICAL PSYCHIATRY (2014)
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
Annalisa Pinna et al.
EXPERIMENTAL NEUROLOGY (2014)
Novel Transgenic Technology Reveals Several Molecular Adaptations and Potential Therapeutic Targets in the Direct Pathway in Levodopa-Induced Dyskinesia
Naomi P. Visanji
MOVEMENT DISORDERS (2014)
Morphologic Changes of Dendritic Spines of Striatal Neurons in the Levodopa-Induced Dyskinesia Model
Haruo Nishijima et al.
MOVEMENT DISORDERS (2014)
Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms
Brigit E. Riley et al.
PLOS ONE (2014)
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
Myriam Heiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology
Antonio Cerasa et al.
FRONTIERS IN NEUROLOGY (2014)
Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Christopher J. Caunt et al.
FEBS JOURNAL (2013)
Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons
Louise M. Collins et al.
NEUROMOLECULAR MEDICINE (2013)
The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
Philippe Huot et al.
PHARMACOLOGICAL REVIEWS (2013)
Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
Grit Taschenberger et al.
ACTA NEUROPATHOLOGICA (2012)
A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP
Alexander Kurz et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
α-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis
David Scott et al.
JOURNAL OF NEUROSCIENCE (2012)
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice
Alessandro Tozzi et al.
NEUROBIOLOGY OF AGING (2012)
Striatal Dopamine Transmission Is Subtly Modified in Human A53Tα-Synuclein Overexpressing Mice
Nicola J. Platt et al.
PLOS ONE (2012)
DUSPs, to MAP kinases and beyond
Ching-Yu Huang et al.
CELL AND BIOSCIENCE (2012)
Genetics of Parkinson's Disease
Christine Klein et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
Christina M. Lill et al.
PLOS GENETICS (2012)
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
Veronica Ghiglieri et al.
PARKINSONS DISEASE (2012)
Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein
Ken Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
Veronica Francardo et al.
NEUROBIOLOGY OF DISEASE (2011)
Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
Mario Gustavo Murer et al.
FRONTIERS IN NEUROANATOMY (2011)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
ALPHA-SYNUCLEIN DEFICIENCY AFFECTS BRAIN FOXP1 EXPRESSION AND ULTRASONIC VOCALIZATION
A. Kurz et al.
NEUROSCIENCE (2010)
A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice
Alexander Kurz et al.
PLOS ONE (2010)
Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats
Ayse Ulusoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
Stefania Fasano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia
M. Angela Cenci et al.
RECENT ADVANCES IN PARKINSONS DISEASE: BASIC RESEARCH (2010)
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA-Induced Dyskinesia and Histone Activation
Sanja Darmopil et al.
BIOLOGICAL PSYCHIATRY (2009)
Dissecting the potential molecular mechanisms underlying a-synuclein cell-to-cell transfer in Parkinson's disease
Elodie Angot et al.
PARKINSONISM & RELATED DISORDERS (2009)
Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both α-synuclein and γ-synuclein
Steven L. Senior et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms
M. Giorgi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Parkinson patient fibroblasts show increased alpha-synuclein expression
Hans-Hermann Hoepken et al.
EXPERIMENTAL NEUROLOGY (2008)
Parkinson's disease
Bobby Thomas et al.
HUMAN MOLECULAR GENETICS (2007)
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
Jenny E. Westin et al.
BIOLOGICAL PSYCHIATRY (2007)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia
M. Angela Cenci
TRENDS IN NEUROSCIENCES (2007)
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease
Flora Mela et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens
Hidetaka Yamada et al.
BRAIN RESEARCH (2007)
Post-versus presynaptic plasticity in L-DOPA-induced dyskinesia
M. Angela Cenci et al.
JOURNAL OF NEUROCHEMISTRY (2006)
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
N Pavon et al.
BIOLOGICAL PSYCHIATRY (2006)
Neural activity controls the synaptic accumulation of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2005)
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-Dopa-induced behavioral sensitization in dyskinetic rats
V Sgambato-Faure et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Social and structural housing conditions influence the development of a depressive-like phenotype in the learned helplessness paradigm in male mice
S Chourbaji et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Genetics of Parkinson's disease
T Gasser
CURRENT OPINION IN NEUROLOGY (2005)
The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation
JJ Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain
E Bezard et al.
NEUROBIOLOGY OF DISEASE (2005)
Increased D-1 dopamine receptor signaling in levodopa-induced dyskinesia
I Aubert et al.
ANNALS OF NEUROLOGY (2005)
Mapk cascade signalling and synaptic plasticity
GM Thomas et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions
S Chandra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
S Gispert et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease:: Relation to motor and cellular parameters of nigrostriatal function
C Winkler et al.
NEUROBIOLOGY OF DISEASE (2002)
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
M Lundblad et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
MA Cenci
AMINO ACIDS (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
